DeepMed Research

Radboud University Medical Center

🇳🇱Netherlands

Country: 🇳🇱Netherlands

Ownership: Private

Established: 1951-01-01

Employees: -

Market Cap: -

Website: http://www.radboudumc.nl

Clinical Trials

Comparison of Three Plasmodium Falciparum Isolates in an Experimental Human Malaria Infection

Not Applicable

Completed

Conditions: Plasmodium Falciparum
Malaria

Interventions: Biological: Exposure to Plasmodium falciparum infected mosquitoes

First Posted Date: 2009-10-27

Last Posted Date: 2010-11-09

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 15

Registration Number: NCT01002833

Locations: 🇳🇱
Leiden University Medical Center, Leiden, Netherlands

Vildagliptin and Endothelium-dependent Vasodilatation

Phase 3

Completed

Conditions: Type 2 Diabetes
Endothelial Dysfunction

Interventions: Drug: vildagliptin + acarbose
Drug: acarbose + vildagliptin

First Posted Date: 2009-10-23

Last Posted Date: 2010-11-05

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 16

Registration Number: NCT01000688

Locations: 🇳🇱
Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands

Efficacy of Hyperbaric Oxygen Therapy in the Treatment of Osteoradionecrosis

Phase 2

Terminated

Conditions: Osteoradionecrosis

Interventions: Drug: hyperbaric oxygen

First Posted Date: 2009-10-06

Last Posted Date: 2017-05-31

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 20

Registration Number: NCT00989820

Locations: 🇳🇱
NKI/AvL, Amsterdam, Netherlands
🇳🇱
VU University Medical centre, Amsterdam, Netherlands
🇳🇱
University Medical Center Groningen, Groningen, Netherlands

and more 5 locations

Short Term Statin Treatment and Endothelial Dysfunction Due to Ischemia and Reperfusion Injury

Phase 4

Completed

Conditions: Ischemia Reperfusion Injury
Endothelial Dysfunction

Interventions: Drug: rosuvastatin
Drug: atorvastatin 3 days
Drug: placebo
Drug: rosuvastatin 7 days
Drug: atorvastatin 7 days
Drug: placebo 7 days

First Posted Date: 2009-10-01

Last Posted Date: 2010-04-28

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 48

Registration Number: NCT00987974

Locations: 🇳🇱
RUNMC, Nijmegen, Netherlands

Pharmacology of Insulin Injected With Jet-Injection

Not Applicable

Completed

Conditions: Diabetes Mellitus, Type 1

Interventions: Device: jet injector (SQ pen/Novopen III)

First Posted Date: 2009-09-24

Last Posted Date: 2011-08-11

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 48

Registration Number: NCT00983775

Locations: 🇳🇱
Radboud University Nijmegen Medical Centre, Nijmegen, P.O. Box 9101, Netherlands

A Study of Combination of Temsirolimus (Torisel®) and Pegylated Liposomal Doxorubicin (PLD, Doxil®/Caelyx®) in Advanced or Recurrent Breast, Endometrial and Ovarian Cancer

Phase 1

Conditions: Advanced/Recurrent Breast Cancer
Endometrial Cancer
Ovarian Cancer

Interventions: Drug: Temsirolimus/PLD

First Posted Date: 2009-09-23

Last Posted Date: 2012-04-11

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 30

Registration Number: NCT00982631

Locations: 🇳🇱
University Medical Center Nijmegen st Radboud, Nijmegen, Gelderland, Netherlands

Overactive Bladder (OAB) Drink Advice Study

Not Applicable

Withdrawn

Conditions: Overactive Bladder Syndrome

Interventions: Dietary Supplement: water

First Posted Date: 2009-09-23

Last Posted Date: 2012-07-24

Lead Sponsor: Radboud University Medical Center

Registration Number: NCT00982241

Locations: 🇳🇱
Dept. of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, Gelderland, Netherlands

Interaction in Chronic Obstructive Pulmonary Disease Experiment

Not Applicable

Completed

Conditions: Chronic Obstructive Pulmonary Disease
Cardiovascular Disease
Smoking
Bronchodilation

Interventions: Drug: Tiotropium (Spiriva) + Salbutamol (Ventolin)
Drug: placebo

First Posted Date: 2009-09-22

Last Posted Date: 2011-07-06

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 40

Registration Number: NCT00981851

Locations: 🇳🇱
University Center for Chronic Diseases Dekkerswald, Groesbeek, Netherlands
🇳🇱
Primary care, general practitioners, Nijmegen, Netherlands

Study of the Immunoresponse in Patients Treated With a Tyrosine Kinase Inhibitor

Completed

Conditions: Renal Cell Carcinoma
GIST

Interventions: Biological: influenza vaccine

First Posted Date: 2009-09-18

Last Posted Date: 2010-03-18

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 75

Registration Number: NCT00979381

Locations: 🇳🇱
University Medical Center Nijmegen st Radboud, Nijmegen, Netherlands

Study on the Influence of Sunitinib and Sorafenib on Fatigue, QoL, Depression in Patients With Metastatic RCC or GIST

Completed

Conditions: Colorectal Cancer
GIST
Renal Cell Cancer

Interventions: Other: Questionnaires

First Posted Date: 2009-09-18

Last Posted Date: 2017-11-28

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 100

Registration Number: NCT00979329

Locations: 🇳🇱
University Medical Center Nijmegen st Radboud, Nijmegen, Netherlands

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy